Deficiency of BPOZ2 Decreases Liver Fibrosis After Chronic Carbon Tetrachloride Administration in Mice

Int J Toxicol. 2015 Mar-Apr;34(2):204-10. doi: 10.1177/1091581814566472. Epub 2015 Jan 7.

Abstract

Bood POZ containing gene type 2 (BPOZ2), a Broad-Complex, Tramtrack, and Bric a brac domain containing protein, is an adaptor protein for the E3 ubiquitin ligase scaffold protein CUL3. It plays an important role in acute carbon tetrachloride (CCl4)-induced liver injury and regeneration in mice. In this study, we investigated the role of BPOZ2 in the process of liver fibrosis induced by chronic CCl4 treatment. The results indicate that BPOZ2 deficiency decreases sustained activation of hepatic stellate cells, attenuates collagen αI(I) and tissue inhibitor of matrix metalloprotease 1 expression, and decreases liver fibrosis after repeated CCl4 administration. These findings suggest BPOZ2 as a new therapeutic target for the prevention and treatment of hepatic fibrosis in chronic liver disease.

Keywords: BPOZ2; HSC; TIMP-1; carbon tetrachloride; liver fibrosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Carbon Tetrachloride / toxicity*
  • Collagen / analysis
  • Female
  • Liver / chemistry
  • Liver / drug effects
  • Liver / pathology
  • Liver Cirrhosis / chemically induced*
  • Liver Cirrhosis / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nuclear Proteins / deficiency*
  • Nuclear Proteins / physiology
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Abtb2 protein, mouse
  • Nuclear Proteins
  • Collagen
  • Carbon Tetrachloride